3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
63
Ovarian Neoplasms
8
Neoplasm Metastasis
8
Endometrial Neoplasms
6
Neoplasms
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Hereditary Sensory and Autonomic Neuropathies
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Breast Cancer
4
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms by Site
3
Colorectal Neoplasms
3
Breast Diseases
3
Small Cell Lung Carcinoma
2
Melanoma
2
Locally Advanced (Inoperable) or Metastatic Breast Cancer
2
Head and Neck Neoplasms
2
Uterine Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Unilateral Breast Neoplasms
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Salivary Gland Neoplasms
1
Recurrence
1
Multiple Endocrine Neoplasia Type 1
1
Lung Neoplasms
1
Locoregional Recurrence
1
Interventions
Cyclophosphamide
28
Rituximab
23
fludarabine
14
fludarabine phosphate
12
Specimen Handling
11
obinutuzumab
10
ibrutinib
10
Magnetic Resonance Spectroscopy
10
Prednisone
8
Doxorubicin
8
tocilizumab
7
polatuzumab vedotin
7
X-Rays
7
Whole-Body Irradiation
7
Phantoms, Imaging
7
Mycophenolic Acid
7
Etoposide
7
Biopsy
7
venetoclax
6
glofitamab
6
Melphalan
6
Lenalidomide
6
Bendamustine Hydrochloride
6
pirtobrutinib
5
acalabrutinib
5
Vincristine
5
Peripheral Blood Stem Cell Transplantation
5
Nuclear Medicine Department, Hospital
5
Nivolumab
5
Gemcitabine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
Fulvestrant
×
90 days
×
Clear all
No trials found.